DAVID JOSLYN: Open Payments
NPI 1639143076 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 42 payments from 16 companies in 2025. Trend: 2023 $186 · 2024 $782 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 4 | $115 |
| Ascendis Pharma Endocrinology Inc | 4 | $105 |
| BETA BIONICS, INC. | 4 | $99 |
| IBSA Pharma Inc. | 5 | $92 |
| Amneal Pharmaceuticals LLC | 3 | $81 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $79 |
| Tandem Diabetes Care, Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $71 |
| Fidia Pharma USA Inc. | 3 | $51 |
| Amgen Inc. | 3 | $50 |
Products named: TWIIST, Yorvipath, iLet Bionic Pancreas, Tirosint, UNITHROID, JOURNAVX, t:slim X2 Insulin Pump with Control-IQ, JARDIANCE.
Industry payments across NY — which companies pay providers there.
